Quick Search

 

 


 

 

Result Summary for 101468/173

Result Summary
Protocol ID: 101468/173
Clinical Study ID: 101468/173
Official Title: Open study to evaluate the safety and efficacy of ropinirole (Requip) in the treatment of new Parkinson Patients or Parkinson patients switching from another dopamine agonist.
Phase: Phase 4
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: requip;requip
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.